Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 6:00 PM EDT

145.90

-0.24 (-0.16%)

Volume

712,629

146.14

-0.68 (-0.46%)

Volume

5,461,897

52 week range

143.13 - 175.97

Open146.70
Day High147.18
Day Low145.95
Prev Close146.82
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24

Key Stats

Market Cap352.166B
Shares Out2.41B
10 Day Average Volume9.50M
Dividend4.96
Dividend Yield3.39%
Beta0.54
YTD % Change-6.76

KEY STATS

Open146.70
Day High147.18
Day Low145.95
Prev Close146.82
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24
Market Cap352.166B
Shares Out2.41B
10 Day Average Volume9.50M
Dividend4.96
Dividend Yield3.39%
Beta0.54
YTD % Change-6.76

RATIOS/PROFITABILITY

EPS (TTM)7.55
P/E (TTM)19.35
Fwd P/E (NTM)13.83
EBITDA (TTM)29.873B
ROE (TTM)18.31%
Revenue (TTM)81.796B
Gross Margin (TTM)70.22%
Net Margin (TTM)22.92%
Debt To Equity (MRQ)42.65%

EVENTS

Earnings Date07/17/2024(est)
Ex Div Date05/20/2024
Div Amount1.24
Split Date-
Split Factor-

Latest On Johnson & Johnson

Jim Cramer's favorite investment themes in tough markets and 3 stocks he likes nowApril 25, 2024CNBC.com
A rapid-fire update on our 33 stocks including the tech giants reporting this weekApril 24, 2024CNBC.com
Why this is perfect time to buy health-care stocks, one financial advisor saysApril 23, 2024CNBC.com
Ford surges on Tesla's EV price cuts as legacy automaker falls back on its rootsApril 22, 2024CNBC.com
Cramer’s Mad Dash: Johnson & JohnsonApril 19, 2024CNBC.com

Content From Our Affiliates

Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85MApril 24, 2024TipRanks
Johnson & Johnson management to meet with OppenheimerApril 24, 2024TipRanks
Legend Biotech says Carvykti approved by EC for second-line multiple myelomaApril 22, 2024TipRanks
Stryker added to ‘Tactical Outperform’ list at Evercore ISIApril 22, 2024TipRanks
Johnson & Johnson (NYSE:JNJ) Notches Up After Talc WinApril 19, 2024TipRanks

Profile

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, General Counsel

John Reed M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	131.20	+0.48	+0.37%
ABBV AbbVie Inc	159.62	-7.67	-4.58%
RHHBY Roche Holding AG	30.25	+0.23	+0.77%
AZN AstraZeneca PLC	75.17	+0.14	+0.19%
NVS Novartis AG	97.44	-1.62	-1.64%